Table 1 Clinicopathological characteristics of the study population (n = 327)
From: Clinical implication of the BRAFV600E mutation in papillary thyroid carcinoma
Characteristics | Value |
|---|---|
Age, years, | |
mean ± SD | 47.79 ± 11.03 |
range | |
≥45 | 210 (64.2%) |
<45 | 117 (35.8%) |
Sex, | |
male | 59 (18%) |
female | 268 (82%) |
Tumour size, cm, | |
mean ± SD | 1.04 ± 0.73 |
≤1 cm | 213 (65.1%) |
>1 cm | 114 (34.9%) |
Extrathyroidal extension | 192 (58.7%) |
BRAFV600E mutation | 241 (73.7%) |
Lymph node metastasis | 147 (45%) |
Central node metastasis | 145 (44.3%) |
Lateral node metastasis | 28 (8.6%) |
TNM stage | |
I | 137 (41.9%) |
II | 40 (12.2%) |
III | 121 (37.0%) |
IVA | 18 (8.9%) |
Extent of surgery | |
Total thyroidectomy | 270 (82.6%) |
Hemithyroidectomy | 55 (16.8%) |
Completion thyroidectomy | 2 (0.6%) |
Hashimoto thyroiditis | 56 (17.1%) |